Karen Phillips Email and Phone Number
Karen Phillips work email
- Valid
- Valid
Karen Phillips personal email
- Valid
A biotechnology champion with a breadth of experience and highly qualified in:Market Access and Field Medical Strategy Development- Deliver vision and direction that creates evidence generation establishing a portfolio’s value and proposition to execute cross-functional product strategy.Patient Access and Outcomes Enhancement- Expand coverage strategies and medical plans by generating value messaging utilizing health economic, real-world, and clinical data based on an understanding of decision makers' needs and the US reimbursement system. Decision-Making Strategies-Offer direction for value-based agreements (VBAs), medical policy, HEOR collaborations, and payer-related issues related to US reimbursement and coverage for the product portfolio. Value Proposition- Communicate the value proposition from a neutral viewpoint utilizing clinical data, real-world evidence (RWE), pharmacoeconomics, and health economics and outcomes research (HEOR) for marketed and pipeline products. Relationships/Stakeholder Engagement- Develop and sustain collaborative relationships with key decision-makers of National and Regional payer customers. Incorporate field medical with account teams, internal Medical Affairs, and cross-functional evidence generation partners, guaranteeing a comprehensive approach to accounts driving company initiatives.Vision- Blend internal and external insights identifying gaps in drug/brand development and evidence generation to advise, progress, and support medical and brand strategies, health outcomes, and research priorities. Launch Excellence- Contribute strategy and scientific leadership for US launch campaigns, label expansions, and support for compounds in various stages of clinical development, including integrated strategic planning and development of effective evidence-generation strategies, medical education, and scientific communication strategies.
Sarepta Therapeutics
View-
Global Market Access (Contractor)Sarepta Therapeutics Jul 2024 - PresentCambridge, Ma, Us
-
Associate Director Health Economics & Outcomes ResearchNovartis Jul 2023 - May 2024Basel, Baselstadt, ChPartner cross-functionally to deliver innovative HEOR evidence-generation strategies and tactics to support global reimbursement, health technology assessment (HTA), and patient access to cardiovascular therapeutics.• Drive successful HTA submissions with effective global value dossiers, budget impact & cost-effectiveness models focusing on top 10 Countries (e.g. Canada, China, Japan, France).• Strategic partner developing & delivering country-specific HEOR, creating optimal product positioning & fulfilling HTA specifications.• Generate HEOR differentiating siRNA PCSK9i enabling reimbursement submissions/negotiations globally.• Develop annual HEOR strategy, tactical plan, and budget; obtain global senior leadership endorsement. • Create HEOR to address access-related evidence gaps, harmonized with the global integrated evidence generation plan.• Manage annual evidence generation budget, publications, and external vendor relationships/contracts. • Accountable for data accuracy & product strategy alignment for country & global abstracts, posters, & publications. -
Business Performance DirectorAmgen Nov 2021 - Jun 2023Thousand Oaks, Ca, UsSelected for a growth opportunity to expand knowledge of commercialization, R&D, and program management by leading enterprise strategic transformations. Led teams, eliminated barriers, mitigated risks, and delivered recommendations to stakeholders and executive sponsors to inform decision-making. Accelerated priority assests for commercialization. • Executed Program Management for $MM end-to-end transformations creating critical SVP/VP communications, driving achievement of GMIP goals, designed and led quarterly enterprise-wide planning meetings. • Accelerated drug development timelines: identified a ~23-month reduction from candidate seeking to proof-of-concept and de-risked a Phase 3 program detecting 37 accelerations with 10 efficiencies conferring time reductions ranging from 2-16 weeks. Employed agile methods, facilitated decision-making, identified barriers, and co-created solutions enabling innovation and continuous improvement. • Expedited commercialization by directing the product teams to identify critical path milestones, mitigate risks, and remove barriers, to achieve theoretical minimum cycle and program timelines. • Talent Marketplace Project (Global Value and Access): synthesized learnings from payer negotiations in key EU markets. Analyzed negotiation techniques to inform drug development and launch strategies. (July 2022 - February 2023). -
National Account Director U.S. Medical Value & AccessAmgen May 2019 - Nov 2021Thousand Oaks, Ca, UsPromoted to a new strategic role. Developed and evolved the capability demonstrating the value of clinical NADs. Provided comprehensive account management as the clinical SME, ensuring access to Amgen’s portfolio, established relationships with key decision makers, and facilitated real-world evidence generation with external stakeholders to improve patient outcomes. • Created and implemented innovative best practices; recognized by executive leadership for 3 national payers, 2 PBMs, 1 specialty pharmacy, and 1 pathway organization, encompassing over 1B commercial & government lives.• Conveyed the clinical and economic value for 23 complex molecules, utilizing pivotal trials, RWE, BIMs, and cost-effectiveness analyses leading to a reduction in 2-3 access barriers and 3-4 formulary additions annually across 5 therapeutic areas. • Generated market insights to inform evidence-generation strategies to mitigate access barriers. • Collaborated cross-functionally with commercial market access and brand teams, ensuring comprehensive payer engagements; created strategic account plans supporting the medical organization’s goals. • Established relationships: executed account research yielding innovative engagements with venture funds & researchers expanding and enhancing account contacts. • Assessed 100+ payer policies annually identifying opportunities to engage customers and reduce access barriers.• Led the NAD team to develop a standardized internal communication process among 15 national and 50+ regional payers improving team efficiencies and driving alignment of account initiatives. • Led global training for 200+ employees on value insights generation for the Global Medical Value & Access capability initiative delivering on R&D’s priority of enabling medication access.
-
Patient Outcomes And Policy Regional ExecutiveAmgen May 2017 - May 2019Thousand Oaks, Ca, UsSelected by the CMO for a customer-facing pilot team to ensure market share retention by adapting Amgen's business model in response to the Oncology Care Model (OCM). Evolved health care delivery, and developed innovative solutions throughout the patient journey to match OCM participants needs. Comprehensive attention on the OCM, population health, process improvement, government policy, health economics, and project management.• Gathered and analyzed OCM provider data determining the APM implications on oncology care delivery. • Created strategic business recommendations for the executive steering committee, driving pilot team activities. • Pioneered methods to identify two provider resources to optimize OCM outcomes.
-
Senior Health Outcomes Pharmacoeconomics SpecialistAmgen Dec 2015 - May 2017Thousand Oaks, Ca, Us
-
Senior Medical Science LiaisonAmgen May 2015 - Dec 2015Thousand Oaks, Ca, Us
-
Board Of DirectorsFamilies For Depression Awareness Jun 2020 - Jun 2021Waltham, Ma, Us -
Senior PharmacistMass General Brigham (Previously: Partners Healthcare) May 2013 - May 2015Partners HealthCare is a not-for-profit health care system, founded by Brigham and Women's Hospital and Massachusetts General Hospital, comprised of community and specialty hospitals, managed care organization, physician network, company-owned Managed Medicaid Plan, and other entities. Partners HealthCare is a teaching affiliate of Harvard Medical School, and a national leader in biomedical research.Provide expert strategic formulary management of traditional and specialty medications for Partners community, specialty and academic medical centers. Implement the Center’s mission to optimize cost-effective medication use and improve patient care across the system. Project the demand for and manage high cost medications; develop and implement clinical guidelines; identify all viable drug cost-reduction opportunities; conduct extensive drug utilization reviews; and perform ongoing assessment of the impact of clinical guidelines on drug expenditures. Actively improve processes by standardizing and streamlining the formulary and drug review process.Identify, develop, and implement 6 to 10 new drug policies annually, while simultaneously managing the development and implementation of 3 to 4 drug policies at any one time, for the health system.Created, and currently facilitate, a strategic cross-functional system-wide Pharmacy and Therapeutics Committee of 35 stakeholders from community, specialty, and nationally renowned academic medical centers, and the Managed Medicaid Health Plan.
-
Clinical PharmacistMass General Brigham (Formulary Partners Healthcare) Jan 2009 - May 2013Began with Partners Healthcare as a Clinical Pharmacist for Partners Community Healthcare Inc. (PCHI), a for-profit subsidiary of Partners HealthCare, with more than 1,000 internists, pediatricians and family practice physicians and over 3,500 specialists who provide care to more than 1.5 million patients. Clinical Content subject matter expert responsible for managing a commercial self-insured drug formulary, as well as providing guidance to network physician groups to improve cost-effective medication utilization. Consulted with provider groups to optimize medication regimens for high-risk patient populations, meeting organizational goals of improvement in patient care and decreased hospital re-admissions. Performed retrospective drug utilization reviews based on pharmacy claims data and electronic medical records to assess attainment of clinical therapeutic goals, appropriate prescribing, and medication misuse for provider practices.
Karen Phillips Skills
Karen Phillips Education Details
-
University Of FloridaPost-Graduate Certificate In Pharmacoeconomics -
Massachusetts College Of Pharmacy And Health SciencesPharmacy
-
Ohio Northern UniversityDoctor Of Pharmacy (Pharm.D.)
Frequently Asked Questions about Karen Phillips
What company does Karen Phillips work for?
Karen Phillips works for Sarepta Therapeutics
What is Karen Phillips's role at the current company?
Karen Phillips's current role is Senior leader with expertise in market access, HEOR, and business strategy offering a distinctive interpretation of market insights, clinical evidence, and economic analyses to mitigate reimbursement access barriers..
What is Karen Phillips's email address?
Karen Phillips's email address is ka****@****ail.com
What schools did Karen Phillips attend?
Karen Phillips attended University Of Florida, Massachusetts College Of Pharmacy And Health Sciences, Ohio Northern University.
What skills is Karen Phillips known for?
Karen Phillips has skills like Managed Care, Healthcare, Pharmacy, Clinical Research, Clinical Pharmacy, Pharmacists, Pharmacy Benefit Management, Evidence Based Medicine, Medication Therapy Management, Medical Writing, Medical Education, Pharmacy Practice.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial